← Back to Discover
TYBOURNE CAPITAL MANAGEMENT (HK) LTD
Period ended Sep 30, 2025 · Latest filing Nov 6, 2025
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2025: $30,933,557
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2025. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- TAYSHA GENE THERAPIES INC (TSHA US) · COM SHS · 877619106 · shares: $12,099,000
- FORTE BIOSCIENCES INC (FBRX US) · COM NEW · 34962G208 · shares: $11,799,705
- ALUMIS INC (ALMS US) · COM · 022307102 · shares: $5,583,008
- ZENTALIS PHARMACEUTICALS INC (ZNTL US) · COM · 98943L107 · shares: $1,451,844
Reported holdings
4 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| TAYSHA GENE THERAPIES INC (TSHA US) | COM SHS | 877619106 | — | 3,700,000 shares | $12,099,000 |
| FORTE BIOSCIENCES INC (FBRX US) | COM NEW | 34962G208 | — | 786,647 shares | $11,799,705 |
| ALUMIS INC (ALMS US) | COM | 022307102 | — | 1,399,250 shares | $5,583,008 |
| ZENTALIS PHARMACEUTICALS INC (ZNTL US) | COM | 98943L107 | — | 961,486 shares | $1,451,844 |